Status:
RECRUITING
Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
Lead Sponsor:
Nantes University Hospital
Conditions:
Acute Hidrosadenitis
Eligibility:
All Genders
Brief Summary
Our primary objective with this cohort will be to define the different phenotypes of acute hidrosadenitis, the characterization of which is essential to define suitable therapeutic approaches. Indeed,...
Eligibility Criteria
Inclusion
- Patient diagnosed with acute hidrosadenitis by a dermatologist
- Patient agreeing to be part of the study
Exclusion
- Major under guardianship
- Protected persons
Key Trial Info
Start Date :
January 4 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 20 2030
Estimated Enrollment :
465 Patients enrolled
Trial Details
Trial ID
NCT04352036
Start Date
January 4 2022
End Date
February 20 2030
Last Update
September 5 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France, 49933
2
Chru Brest
Brest, France
3
CHD Vendée
La Roche-sur-Yon, France
4
CH La Rochelle
La Rochelle, France